2020

• February - Steve Deeks, MD - Clinical Trials Update and Consultation

• April - Sharon Lewin, FRACP, PhD - The Role of Immune Checkpoint Blockers in HIV Cure - A Good or Bad Idea?

• ​May - Michael Peluso, MD - Best Practices To Mitigate HIV Transmission Risk During Analytic Treatment Interruption (ATI) Report From A Community-Biomedical-Social Science Part

• ​June - Steve Deeks, MD & Michael Peluso, MD - ATIs During the COVID-19 Era

 

2019

• January - Richard F. Ambinder, M.D., Ph.d - Bloodbone marrow transplantation for patients with HIV and the possibilities for cure

• February - Marina Caskey, MD & Tae-Wook Chun, PhD - Update on Broadly Neutralizing Antibodies in HIV Cure Research

• March - Tim Henrich, MD - Imaging HIV Persistence

• May - Lynda Dee, Esq & Richard Jeffreys - ATI Update

• June - Steve Deeks, MD - DARE Program Update and Cosultation

• July - Steve Deeks, MD & Sharon Lewin, FRACP, PhD - DARE Research Agenda

• September - Steve Deeks, MD & Karine Dube, DrPH - Social Science Study

• October - Eileen Scully, MD, PhD - Keeping up with the cure: Taking care to include women

• November - Xu Yu, MD - Proviral landscape of HIV in elite controllers

 

2018

• January - Jake Estes PhD - Defining Total – Body AIDS – Virus Burden with Implications for Curative Strategies

• March - Steve Deeks, MD & Richard Price MD - Safety Related Issues Related to Analytic Treatment Interruptions

• May - Tae-Wook Chun, PhD - Achieving Antiretroviral Therapy-Free HIV Remission: How to get there?

• August - Mary Kearney, PhD - HIV-1 is Maintained on ART by the Proliferation of Infected Cells, Not from Viral Spread

• ​September - Steve Deeks, MD - amfAR trial presentation

• ​October - Brad Jones, PhD - Current Innovations in HIV Cure-related and Vaccine Research

​